Impact of Frailty and ICU-AW on Post-ICU Fatigue Self-reported
- Conditions
- Post Intensive Care Syndrome
- Registration Number
- NCT05984069
- Brief Summary
After a prolonged stay in Intensive Care Unit (ICU), fatigue is the most common symptom reported by patients in the Post Intensive Care Syndrome (PICS). Other complications have been described, including ICU-acquired weakness, leading to increased morbidity and mortality after discharge. Actually, risk factors associated with post-ICU fatigue self-reported are not really known.
- Detailed Description
Frailty, defined as a decrease in physiological reserves leading to an alteration in the mechanisms of adaptation to stress, increases the incidence of PICS and could therefore be a cause of post-ICU fatigue self-reported.
The aim of this study is to identify a relationship between markers of frailty, ICU-AW, ICU story and the post-ICU fatigue self-reported 6 months discharge in patients with prolonged ICU stays.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- Patients with a length of stay in intensive care > or equal to 7 days, or mechanical ventilation > or equal to 5 days
- Scheduled surgery with admission in ICU
- Pregnancy
- Guardianship
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frailty 1 year Relationship between frailty markers (CFS, IADL, sarcopenia and myosteatosis), ICU-AW, ICU story and post-ICU fatigue self-reported
- Secondary Outcome Measures
Name Time Method Kinetic of muscle mass loss and post-ICU fatigue self-reported 1 year Correlation between the kinetic of muscle mass loss and post-ICU fatigue self-reported
ICU-acquired weakness and fatigue 1 year Correlation between post-ICU fatigue self-reported and muscular strength assessed by handgrip test
Fatigue, quality of life, anxiety and depressive disorder 1 year Correlation between fatigue, quality of life, anxiety and depressive disorder
Fatigue 1 year Prevalence of post-ICU fatigue self-reported 6 months discharge in prospective cohort
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
Chu Saint-Etienne
🇫🇷Saint-etienne, France
Hôpital Privé de la Loire
🇫🇷Saint-Étienne, France
Chu Saint-Etienne🇫🇷Saint-etienne, FranceJérôme MOREL, MD PhDPrincipal InvestigatorNory ELHADJENE, MDSub Investigator